Sumi E - Search Results

1

Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol.

Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N. Sumi E, et al. J Transl Med. 2014 Nov 25;12:310. doi: 10.1186/s12967-014-0310-2. J Transl Med. 2014. PMID: 25421542 Free PMC article. Clinical Trial.

2

Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer.

Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka Y, Hamazaki Y, Minato N, Toi M. Sugie T, et al. Among authors: sumi e. Breast. 2018 Apr;38:114-119. doi: 10.1016/j.breast.2017.12.017. Epub 2018 Jan 5. Breast. 2018. PMID: 29310035 Clinical Trial.

3

The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial.

Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, Uozumi R, Tada H, Nakagawa T, Hagiwara M, Kabashima K. Nomura T, et al. Among authors: sumi e. Trials. 2019 Aug 9;20(1):489. doi: 10.1186/s13063-019-3570-6. Trials. 2019. PMID: 31399147 Free PMC article.

4

Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial.

Ikeda HO, Muraoka Y, Hata M, Sumi E, Ikeda T, Nakagawa T, Abe H, Tada H, Morita S, Kakizuka A, Yoshimura N, Tsujikawa A. Ikeda HO, et al. Among authors: sumi e. PLoS One. 2020 Feb 13;15(2):e0229068. doi: 10.1371/journal.pone.0229068. eCollection 2020. PLoS One. 2020. PMID: 32053676 Free PMC article. Clinical Trial.

5

An eClinical trial system for cancer that integrates with clinical pathways and electronic medical records.

Yamamoto K, Yamanaka K, Hatano E, Sumi E, Ishii T, Taura K, Iguchi K, Teramukai S, Yokode M, Uemoto S, Fukushima M. Yamamoto K, et al. Among authors: sumi e. Clin Trials. 2012 Aug;9(4):408-17. doi: 10.1177/1740774512445912. Epub 2012 May 17. Clin Trials. 2012. PMID: 22605791 Free article.

6

The correlation between the number of eligible patients in routine clinical practice and the low recruitment level in clinical trials: a retrospective study using electronic medical records.

Sumi E, Teramukai S, Yamamoto K, Satoh M, Yamanaka K, Yokode M. Sumi E, et al. Trials. 2013 Dec 11;14:426. doi: 10.1186/1745-6215-14-426. Trials. 2013. PMID: 24326039 Free PMC article.

7

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.

Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, Inoue N, Shibuya M, Okamoto N, Mitsuishi T, Uozumi R, Tada H, Nakagawa T, Kusuba N, Okuno A, Shimizuhira C, Ishikawa M, Tanaka S, Hagiwara M, Kabashima K. Nomura T, et al. Among authors: sumi e. JID Innov. 2021 May 20;1(3):100026. doi: 10.1016/j.xjidi.2021.100026. eCollection 2021 Sep. JID Innov. 2021. PMID: 34909725 Free PMC article. Clinical Trial.

8

A pragmatic method for electronic medical record-based observational studies: developing an electronic medical records retrieval system for clinical research.

Yamamoto K, Sumi E, Yamazaki T, Asai K, Yamori M, Teramukai S, Bessho K, Yokode M, Fukushima M. Yamamoto K, et al. Among authors: sumi e. BMJ Open. 2012 Oct 31;2(6):e001622. doi: 10.1136/bmjopen-2012-001622. Print 2012. BMJ Open. 2012. PMID: 23117567 Free PMC article.

9

Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts.

Sumi E, Nomura T, Asada R, Uozumi R, Tada H, Amino Y, Sawada T, Yonezawa A, Hagiwara M, Kabashima K. Sumi E, et al. Clin Drug Investig. 2019 Jan;39(1):55-61. doi: 10.1007/s40261-018-0712-7. Clin Drug Investig. 2019. PMID: 30284700 Free PMC article. Clinical Trial.

10

Clinical trial to evaluate the therapeutic benefits of limbal-supported contact lens wear for ocular sequelae due to Stevens-Johnson syndrome/toxic epidermal necrolysis.

Itoi M, Ueta M, Ogino K, Sumi E, Imai K, Teramukai S, Kinoshita S, Sotozono C. Itoi M, et al. Among authors: sumi e. Cont Lens Anterior Eye. 2020 Dec;43(6):535-542. doi: 10.1016/j.clae.2020.05.007. Epub 2020 Jun 5. Cont Lens Anterior Eye. 2020. PMID: 32513522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters